StockGlow

Astellas Pharma Inc. (ALPMF)

Develops medicines for cancer, eye disease, bladder problems, and other serious conditions

$13.15+0.02%Healthcare
Compare ALPMF with
StockGlow Score
26
Leaning Bearish
BearishBullish
1 year ago+25.7%

The outlook

ALPMF is trading below both its 50- and 200-day moving averages, sitting roughly midway in its 52-week range. The stock carries a trailing P/E of 13.3 and shows a bearish lean according to current sentiment metrics. Analyst coverage appears limited for this ADR.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range43% of the way from its 52-week low to high
Market cap
$23.56B
52-wk high
$17.85
52-wk low
$9.54
50-day avg
$13.91
200-day avg
$13.90
Trailing P/E
13.3

Similar stocks

ALPMYAstellas Pharma Inc.$13.64+1.56%DSKYFDaiichi Sankyo Company, Limited$17.50+9.72%TKPHFTakeda Pharmaceutical Company Limited$32.60+4.52%CHGCYChugai Pharmaceutical Co., Ltd.$21.41+2.44%BAYZFBayer Aktiengesellschaft$52.50-0.57%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy